Overview
Gonadorelin is classified as a PCT (post-cycle therapy) and ancillary compound. Endogenous decapeptide (10 amino acids).
With a half-life of ~4 minutes, Gonadorelin requires daily administration in most observed protocols. Administered via SubQ injection, it has a bioavailability of approximately 80% via its primary route.
Extremely short half-life (~2–4 minutes) due to rapid enzymatic cleavage. Pulsatile release pattern in vivo. Subcutaneous administration. One-compartment model.
Mechanism of Action
Gonadorelin's pharmacological activity involves the following key pathways:
GnRH Signaling
Gonadorelin acts on the hypothalamic-pituitary axis through GnRH receptor activation, stimulating pulsatile gonadotropin release.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
50 mcg/day
Route
Subcutaneous
Frequency
2-3 times daily
Duration
4-8 weeks
Dose
100 mcg/day
Route
Subcutaneous
Frequency
2-3 times daily
Duration
4-8 weeks
Reconstitution Steps
Gonadorelin is supplied as a lyophilized (freeze-dried) powder and requires reconstitution before use. Common vial sizes: 2 mg, 10 mg.
-
1
Gather supplies
You will need your Gonadorelin vial (lyophilized powder), bacteriostatic water, an insulin syringe for mixing, additional insulin syringes for dosing, alcohol swabs, and a sharps container.
-
2
Clean and prep
Wipe the rubber stoppers of both the Gonadorelin vial and BAC water vial with separate alcohol swabs. Allow 10–15 seconds to air-dry before inserting any needle.
-
3
Draw BAC water
Draw 2 mL of bacteriostatic water. This volume with a 2 mg vial gives a concentration of 1 mg/mL (1,000 mcg/mL), making standard 100–200 mcg doses easy to measure at 0.1–0.2 mL.
-
4
Add water to Gonadorelin
Slowly inject the BAC water along the inner wall of the Gonadorelin vial. Swirl very gently — do not shake. Gonadorelin is a short peptide and more fragile than larger glycoprotein hormones. The solution should be clear and colourless.
-
5
Label and store
Label with the reconstitution date and concentration (e.g., 2 mg / 2 mL = 1,000 mcg/mL). Refrigerate at 2–8°C immediately. Use within 7–14 days. Due to twice-daily dosing, a 2 mg vial is typically consumed within 5–10 days.
Quick Reconstitution Math
2 mg vial + 2 mL BAC water = 1,000 mcg/mL. A 100 mcg dose = 0.1 mL (10 units on a 100-unit insulin syringe). A 200 mcg dose = 0.2 mL (20 units). Use the Milligram reconstitution calculator for custom vial sizes.
Reconstituted Gonadorelin is stable for 7–14 days refrigerated at 2–8°C. Lyophilized powder is stable refrigerated. Protect from light and heat at all stages. Do not freeze reconstituted solution — Gonadorelin is more fragile than glycoprotein hormones like HCG.
Frequently Asked Questions
What is Gonadorelin and how does it work?
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH) that is chemically identical to the endogenous peptide produced by the hypothalamus. It works by binding to GnRH receptors on the pituitary gland, triggering the pulsatile release of both LH and FSH – the upstream signals that drive testicular testosterone and sperm production. Unlike HCG, which bypasses the pituitary and acts directly on the testes, Gonadorelin stimulates the natural hypothalamic-pituitary-testicular (HPT) axis from the top down.
What is the difference between Gonadorelin and HCG for PCT?
Gonadorelin and HCG work at different levels of the endocrine axis. HCG acts directly at the Leydig cells in the testes, mimicking LH to stimulate testosterone production – it bypasses the pituitary entirely. Gonadorelin acts at the pituitary, stimulating the natural release of both LH and FSH, which then signal the testes. This distinction means Gonadorelin may better support recovery of the full HPT axis including pituitary sensitivity, while HCG is faster-acting and more targeted for testicular stimulation.
Why does Gonadorelin need to be dosed so frequently?
Gonadorelin has an extremely short half-life of approximately 2–4 minutes in circulation, as it is rapidly degraded by peptidases. Effective pituitary stimulation requires pulsatile delivery mimicking the hypothalamus's natural GnRH pulse frequency. Community protocols using twice-daily SubQ injections represent a practical approximation of this pulsatile pattern – more frequent delivery (via pump, for example) more closely mirrors endogenous physiology but is impractical for most users.
What is the typical Gonadorelin dose and protocol?
Community-observed dosing ranges from 100–200 mcg per injection, administered subcutaneously twice daily. Some protocols cite use during TRT to maintain HPT axis sensitivity and testicular function as an alternative to HCG. The extremely short half-life means doses must be spaced throughout the day to maintain intermittent pituitary stimulation – a single daily injection would not provide adequate signalling over 24 hours.
Does Gonadorelin desensitize the pituitary if used continuously?
Paradoxically, continuous or high-frequency GnRH exposure causes pituitary downregulation rather than stimulation – this is the mechanism behind GnRH agonist therapy used in certain clinical settings. The key variable is dosing pattern: pulsatile low-frequency delivery stimulates LH and FSH release, while continuous exposure suppresses it. Twice-daily SubQ injections are intended to maintain a pulsatile pattern, though some practitioners recommend cycling on and off to avoid potential receptor desensitization.
How should reconstituted Gonadorelin be stored?
Once reconstituted with bacteriostatic water, Gonadorelin should be refrigerated at 2–8°C and used within 7–14 days depending on the product. As a peptide, it is susceptible to degradation from heat, light, and agitation – handling should be gentle and storage should avoid temperature fluctuations. The lyophilized powder form is more stable and can be kept refrigerated or at cool room temperature until reconstitution.